These are not the Best of times for the pharmaceutical industry. More regulations, increased federal scrutiny, pricing pressures, and a tarnished public image all cloud the present — and future — of the industry. But along with these challenges...

“We don't reject or refute [the Senate Finance Committee's] observations,” says Murray Kopelow, MD, chief executive, Accreditation Council for CME. As the ACCME said in a press release, the report's observations highlight where there could be...

...

Performance-improvement activities, which take education from the hotel ballroom to the physician's office, offer an exciting new way for providers to offer continuing medical education credit. The question is: How do you do it? A session at the...

CME professionals' reactions to the Senate Finance Committee report on medical education run the gamut, from those who agree that pharmaceutical company funding results in biased programming to those who think the committee is wasting its time and...

Two days after it issued its April 25 report on CME, the United States Senate Committee on Finance followed up with a letter to the Accreditation Council for CME, highlighting its concerns that the ACCME’s oversight is insufficient to guarantee...

The Accreditation Council for CME made it very clear at the 2007 Alliance for CME annual meeting that it may not be possible for providers to achieve Level 3 compliance with the updated accreditation criteria by the November 2008 deadline. However...

Let's face it — we're all looking for something or someone. When it comes to CME, it is especially true for learners, educators, providers, and supporters. The problem is, how do we find each other? We know what we want, but we may not know who we...

...

How effective is CME at changing physician behavior? This question has taken on new urgency with the Accreditation Council for CME's updated accreditation criteria, which tasks providers with “addressing issues that prevent [physicians] from...